Hideya Yamazaki

Has grant

Professor

Kyoto Prefectural University of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Hideya Yamazaki is a faculty member at Kyoto Prefectural University of Medicine, Japan. His research focuses on advanced radiation therapies, including brachytherapy techniques and particle beam therapy applications for various cancers. Recent publications include studies on machine learning in treatment decision-making and meta-analyses comparing photon and particle radiotherapy outcomes.

Recent Grants

Grant: Close

Development of non-invasive monitoring system with exhaled gas measurement for respiratory tract inflammation after proton beam therapy.

Open Date: 2021-04-01

Close Date: 2024-03-31

Grant: Close

Development and evaluation of adaptive radiotherapy for cervical cancer using IMRT and interstitial brachytherapy for international standardization

Open Date: 2021-04-01

Close Date: 2024-03-31

Grant: Close

Image guided brachytherapy using transrectal ultrasound / MRI fusion imaging

Open Date: 2021-04-01

Close Date: 2024-03-31

Grant: Close

個別化された舌癌小線源治療への道-多様な口腔内環境を乗り越えて-

Open Date: 2019-04-01

Close Date: 2022-03-31

Grant: Close

Assessing model-based approach for selection of hepatocellular cancer patients for proton therapy

Open Date: 2019-04-01

Close Date: 2022-03-31

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Makoto Yasuda

Kyoto Prefectural University of Medicine

JAPAN

View details

Kei Yamada

JAPAN

View details

Mitsuko Nakata

Assistant Professor

Kyoto Prefectural University of Medicine

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hideya Yamazaki

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (16)

Role of Particle Beam Therapy for Extrahepatic Biliary Cancer—Updated Systematic Review and Meta‐Analysis for Comparison Between Photon and Particle Radiotherapy

A machine learning-based decision support tool for standardizing intracavitary versus interstitial brachytherapy technique selection in high-dose-rate cervical cancer

MRI-Guided Multi-Catheter High-Dose-Rate Interstitial Brachytherapy for Uterine Cervical Cancer

In Regard to Kodaira et al.

Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients’ registration database, Proton-Net

Ultra-High Prostate-Specific Antigen Level: A Potential Very-High-Risk Factor for Localized High-Risk Prostate Cancer

Particle Beam Therapy for Intrahepatic and Extrahepatic Biliary Duct Carcinoma: A Multi-Institutional Retrospective Data Analysis

Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10

Reirradiation for recurrent head and neck carcinoma using high-dose-rate brachytherapy: A multi-institutional study

Could high-dose-rate monotherapy survive beyond stereotactic ablative radiotherapy era for clinically localized prostate cancer?

Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9–10 clinical localized prostate cancer

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer

Fractionation or tumor factors—what matters in carotid blowout syndrome?

Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy

Reirradiation for Nasal Cavity or Paranasal Sinus Tumor—A Multi-Institutional Study

Collaborators (3)

Makoto Yasuda

Kei Yamada

Mitsuko Nakata

Make your next move.